Form D · Venture Capital Fund
Aspire Ventures Precision Medicine Fund, LLC
Lancaster, PA · CIK 0001724843
Offering snapshot reported Dec 13, 2017 · SEC filing
- Reported sold
- $30M Offering amount: $200M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1M Reported outside-investor minimum
- First sale
- Nov 22, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 13, 2017 | Initial | $30,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06c, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-300587
Source: Form D, filed Dec 13, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Essam Abadir | Executive |
| Medicine Manager, Llc Aspire Ventures Precision | Executive |
| Todd Bartos | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
100 North Queen Street Suite 300
Lancaster, PA, 17603
Lancaster, PA, 17603